Indanorex
From Wikipedia, the free encyclopedia
|
Indanorex
|
|
| Systematic (IUPAC) name | |
| 2-(1-aminopropyl)-1,3-dihydroinden-2-ol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H17NO |
| Mol. mass | 191.269 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Indanorex (Dietor) is a stimulant drug which was developed in the 1970s. It has appetite suppressant effects[1] and also has antihypoglycemia effects.[1]
[edit] References
- ^ Giugliano D, Luyckx A, Binder D, Lefebvre P. Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia. International Journal of Clinical Pharmacology and Biopharmacy. 1979 Feb;17(2):76-81.

